#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liver transplant rejection Paraneoplastic neurological syndrome Partial lipodystrophy Carcinoid syndrome Acquired C1 inhibitor deficiency Stress cardiomyopathy Lung adenocarcinoma ABO haemolytic disease of newborn Myelin oligodendrocyte glycoprotein antibody-associated disease Anaemia Kaposi's sarcoma Hyperinsulinism Renal cell carcinoma Hepatitis B Thymic carcinoma More trials…

    Learn about Rare Diseases

    Phenylketonuria – Basic Information Erdheim-Chester disease – Treatment Factor IX deficiency – Basic Information Proteus syndrome – Treatment Lymphatic malformation – Treatment Leiomyosarcoma metastatic – Trials in Disease Mucous membrane pemphigoid – Life with Disease Mantle cell lymphoma stage IV – Basic Information Mantle cell lymphoma stage IV – Trials in Disease Inclusion body myositis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    177LU-PSMA-I&T Glyceryl Trinitrate Enmetazobactam Alitretinoin Lu Ag09222 Dalteparin Sodium Nesolicaftor Nystatin POTASSIUM HYDROXIDE Meropenem Trihydrate Proguanil Hydrochloride Sacituzumab Govitecan RO7284755 Entecavir Pivekimab Sunirine [89ZR]ZR-DFO-CIT-013 Clindamycin Phosphate BGB-16673 Utreglutide Prax-628 More therapies…

    Learn about Your Condition

    Ventricular tachycardia Sleep disorder Metabolic disorder Lung transplant rejection Breast angiosarcoma Pneumonia Haemorrhage Latent tuberculosis Respiratory failure Meniere's disease EGFR gene mutation Blood disorder Crohn's disease Ewing's sarcoma metastatic Prostate cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Perampanel Treatment Before Surgery for Patients with Progressive Glioblastoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Perampanel
    Germany

  • Study on Durvalumab with Carboplatin or Cisplatin and Etoposide for First-Line Treatment in Patients with Extensive Stage Extrapulmonary Small Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Etoposide
    • Carboplatin
    • Cisplatin
    Italy

  • Study on Improving Ovarian Cancer Diagnosis Using Pyruvic Acid and Gadoteric Acid for Patients Suspected of Having Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Pyruvic Acid
    • Gadoteric Acid
    Denmark

  • Study of ISIS 678354 for Patients with Familial Chylomicronemia Syndrome Previously Treated with Volanesorsen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Sweden

  • Study on the Safety of Mitapivat for Adults with Red Blood Cell Membrane Disorders

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Red blood cell abnormality
    Investigated Drugs:
    • Mitapivat
    Denmark The Netherlands

  • Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    France Hungary Italy The Netherlands Poland Romania +1
Previous Page
1 … 555 556 557 558 559 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!